Update by IDA Foundation Leontien Ruttenberg MSc MBA

Introducing IDA Foundation …a not-for-profit supplier of essential medicines and medical supplies since 1972 Our mission: “To improve access to and deliver high-quality medicines and medical supplies at the lowest possible price to low and middle income countries. ”

IDA Foundation: global presence • • Customers in 130+ countries 40+ agents worldwide & 10 locations with stock Head office in Amsterdam (110 employees) Procurement office in Mumbai (65 employees)

Customers and partners NGO & PRIVATE FOUNDATIONS MULTILATERAL FUNDING The Global Fund to Fight Aids, Tuberculosis and Malaria Clinton Health Access Initiative (CHAI) Drug-purchasing facility (provides funding grants) Hosted by WHO Local NGOs The World Bank President’s Emergency Plan for AIDS Relief (PEPFAR) PRESIDENT’S MALARIA INITIATIVE (PMI) World Health Organisation National Ministries of Health (Mo. H) Central Medical Stores GLOBAL DRUG FACILITY (GDF) The Global Health Network MULTILATERAL PROGRAM & FUNDING BILATERAL

IDA Foundation : key facts 2014 • Multi-channel approach • Procurement Services, wholesale & tender proposals • • Portfolio of > 3000 products Stock keeping 750 products Average stock value: € 12 million Increased turnover the years with customer ranging from hospitals to large donors • Emergency response • 4 Global PA contracts (GDF (2), CHAI, PPM) • 2 National PA contracts(Togo, Nigeria) • 30 Audits

IDA Quality Guaranteed quality for pharmaceuticals and medical supplies* (*process may vary depending on risk class) More than quality control ‘on paper’ verification audits, samples Leading in quality innovation: role in MQAS, WHO working groups Own product: registrations in destination country Dedicated pharmacists in our QA / QC teams in NL, Mumbai, China

Update on achievements 2014 Product range: • RMNCH: reviewed portfolio to include UN 13 commodities • NCD: reviewed portfolio, added 26 anti-cancer drugs to be completed in Q 1, 2015 • HIV/AIDS ; increased focus – re-establish value added Quality • Bioequivalence studies Supply Chain Management • Custom – made kitting projects / more complex supply chain solutions

Update on challenges 2014 Product range: • Stock keeping, shelf-life requirements, lead time • Local manufacturing – price differences w/ Asian generics • Registration Lack of standardization in medical devices • No standard list • No standard quality guidelines Quality • Bioequivalence studies • Harmonization QA guidelines • Focus on local manufacturers may jeopardize uniformity (eg Universal) • Complying to different standards costs time/donor money

Any Questions / Feedback? Contact: lruttenberg@idafoundation. org www. idafoundation. org Join us on: IDA. Foundation. Amsterdam IDA_Foundation

Summary • IDA continues to passionately serve unmet needs • Not for profit, independant & transparant • Looking forward to increased harmonization • Partnership approach